FDA Updates Instructions For Reporting Serious Adverse Events Under MoCRA

 
• By Eileen Francis

The US Food and Drug Administration simplifies instructions for filing reports on serious adverse events under the Modernization of Cosmetics Regulation Act; promotes soon-to-launch electronic-reporting platform.

Adverse Event Reporting

More from Regulation

More from Policy & Regulation